Traci LeMasters1, Suresh Madhavan1, Usha Sambamoorthi1, Sobha Kurian2. 1. West Virginia University, School of Pharmacy, Department of Pharmaceutical Systems and Policy, Morgantown, WV, USA. 2. West Virginia University, Mary Babb Randolph Cancer Center, Morgantown, WV, USA.
Abstract
BACKGROUND: Objectives were to compare health-related quality of life (HRQoL) between breast cancer survivors, prostate cancer survivors (PCS), and colorectal cancer survivors (CCS) to matched controls, stratified by short and long-term survivors, by cancer type, and gender. METHODS: By using the 2009 Behavioral Risk Factor Surveillance System, propensity scores matched three controls to adult survivors >1 year past diagnosis (N = 11,964) on age, gender, race/ethnicity, income, insurance status, and region of the USA Chi-square tests and logistic regression models compared HRQoL outcomes (life satisfaction, activity limitations, sleep quality, emotional support, general, physical, and mental health). RESULTS: Although all cancer survivors reported worse general health (p < 0.000) and more activity limitations (p < 0.004) than controls, these disparities decreased among long-term survivors. Short-term PCS and male CCS were more likely to report worse outcomes across additional domains of HRQoL than controls, but PCS were 0.61, 0.63, and 0.70 times less likely to report activity limitations, fair/poor general health, and 1-15 bad physical health days in the past month than male CCS. Breast cancer survivors and female CCS were 2.12 and 3.17, 1.58 and 1.86, and 1.49 and 153, respectively, times more likely to report rarely/never receiving needed emotional support, 1-15 bad mental health days in the past month, and not receiving enough sleep 1-15 days in the past month than PCS and male CCS. CONCLUSIONS: Cancer survivors experience worse HRQoL than similar individuals without a history of cancer and the severity of affected HRQoL domains differ by time since diagnosis, cancer type, and gender.
BACKGROUND: Objectives were to compare health-related quality of life (HRQoL) between breast cancer survivors, prostate cancer survivors (PCS), and colorectal cancer survivors (CCS) to matched controls, stratified by short and long-term survivors, by cancer type, and gender. METHODS: By using the 2009 Behavioral Risk Factor Surveillance System, propensity scores matched three controls to adult survivors >1 year past diagnosis (N = 11,964) on age, gender, race/ethnicity, income, insurance status, and region of the USA Chi-square tests and logistic regression models compared HRQoL outcomes (life satisfaction, activity limitations, sleep quality, emotional support, general, physical, and mental health). RESULTS: Although all cancer survivors reported worse general health (p < 0.000) and more activity limitations (p < 0.004) than controls, these disparities decreased among long-term survivors. Short-term PCS and male CCS were more likely to report worse outcomes across additional domains of HRQoL than controls, but PCS were 0.61, 0.63, and 0.70 times less likely to report activity limitations, fair/poor general health, and 1-15 bad physical health days in the past month than male CCS. Breast cancer survivors and female CCS were 2.12 and 3.17, 1.58 and 1.86, and 1.49 and 153, respectively, times more likely to report rarely/never receiving needed emotional support, 1-15 bad mental health days in the past month, and not receiving enough sleep 1-15 days in the past month than PCS and male CCS. CONCLUSIONS:Cancer survivors experience worse HRQoL than similar individuals without a history of cancer and the severity of affected HRQoL domains differ by time since diagnosis, cancer type, and gender.
Authors: Eric S Zhou; Frank J Penedo; Natalie E Bustillo; Catherine Benedict; Mikal Rasheed; Suzanne Lechner; Mark Soloway; Bruce R Kava; Neil Schneiderman; Michael H Antoni Journal: J Support Oncol Date: 2010 Sep-Oct
Authors: Jeremy W Couper; Anthony W Love; Gillian M Duchesne; Sidney Bloch; Michelle Macvean; Judy V Dunai; Marita Scealy; Anthony Costello; David W Kissane Journal: Med J Aust Date: 2010-09-06 Impact factor: 7.738
Authors: Joanne S Buzaglo; Suzanne M Miller; Jeffery Kendall; Annette L Stanton; Kuang-Yi Wen; John Scarpato; Fang Zhu; Jennifer Lyle; Julia Rowland Journal: J Cancer Surviv Date: 2012-12-11 Impact factor: 4.442
Authors: Robert S Krouse; Lisa J Herrinton; Marcia Grant; Christopher S Wendel; Sylvan B Green; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Susan M Rawl; Eric Matayoshi; Stephen Joel Coons; Mark C Hornbrook Journal: J Clin Oncol Date: 2009-08-31 Impact factor: 44.544
Authors: Mario Renato Azevedo; Cora Luiza Pavin Araújo; Felipe Fossati Reichert; Fernando Vinholes Siqueira; Marcelo Cozzensa da Silva; Pedro Curi Hallal Journal: Int J Public Health Date: 2007 Impact factor: 3.380
Authors: Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas Journal: J Clin Sleep Med Date: 2015-09-15 Impact factor: 4.062
Authors: Roxanne E Jensen; Arnold L Potosky; Carol M Moinpour; Tania Lobo; David Cella; Elizabeth A Hahn; David Thissen; Ashley Wilder Smith; Jaeil Ahn; George Luta; Bryce B Reeve Journal: J Clin Oncol Date: 2017-04-20 Impact factor: 44.544
Authors: Benjamin D Capistrant; Lindsey Lesher; Nidhi Kohli; Enyinnaya N Merengwa; Badrinath Konety; Darryl Mitteldorf; William G West; B R Simon Rosser Journal: Oncol Nurs Forum Date: 2018-07-02 Impact factor: 2.172
Authors: Brynn Fowler; Qian Ding; Lisa Pappas; Yelena P Wu; Lauri Linder; Jeff Yancey; Jennifer Wright; Margaret Clayton; Deanna Kepka; Anne C Kirchhoff Journal: J Cancer Educ Date: 2018-02 Impact factor: 2.037
Authors: Thomas Hyphantis; Panagiota Goulia; Ioannis Zerdes; Solomis Solomou; Elias Andreoulakis; André F Carvalho; Nicholas Pavlidis Journal: Dig Dis Sci Date: 2015-08-20 Impact factor: 3.199
Authors: Justin C Brown; Nevena Damjanov; Kerry S Courneya; Andrea B Troxel; Babette S Zemel; Michael R Rickels; Bonnie Ky; Andrew D Rhim; Anil K Rustgi; Kathryn H Schmitz Journal: Psychooncology Date: 2018-02-20 Impact factor: 3.894